ReviewsLocally recurrent breast cancer after conservation therapy
Section snippets
Characteristics of local-regional recurrences
Although all LRR after BCT generally are grouped together, it is important to appreciate that there are several different types of recurrences that may reflect both cause and patient prognosis. The types of LRR are categorized by location of the breast recurrence in comparison with the primary treated breast carcinoma.
The most common type of LRR, present in 57% to 88% of patients [11], [12], [13], [14], [15], appears at the site of the primary breast cancer and probably represents incomplete
Margin status
One of the most important predictors of increased risk for LRR is pathologic margin status after BCT. Margin status typically is described as negative, close, or positive. Controversy exists in the literature regarding the meaning of a close surgical margin, with definitions ranging from less than 1 cm to less than 1 mm. According to the NSABP, a margin is positive only if tumor cells are present at the inked surface. A close margin requires cancer cells to be within 1 mm of the inked margin
Detection of local recurrence
Patients should be screened for the early detection of LRR by breast imaging and clinical examination. LRRs are detected by mammography alone 42% to 75% of the time, by physical examination alone 10% to 33% of the time, by a combination of the physical examination and mammography in 12% to 25% of the time, and by other imaging techniques such as magnetic resonance imaging (MRI) 5% of the time (Fig. 2)[18], [20], [42]. Some data suggest that MRI may be a sensitive and specific test, in addition
Management of local recurrence
Unlike chest wall recurrences after mastectomy, LRR after BCT typically is not associated with distant metastases [11], [34]. Because it would alter overall treatment decisions, it is reasonable to perform an extent of disease work-up with a computerized tomography scan and bone scan at the time of LRR. Between 5% and 12% of patients will be found to have inoperable disease at the time of diagnosis of LRR [11], [53], [54]. The treatment of choice for LRR historically has been salvage
Prognosis with local recurrence
In contrast to chest wall recurrence after mastectomy in which the incidence of simultaneous metastatic disease is between 25% and 50%, LRR after BCT typically is not associated with distant metastases [11], [34]. The overall survival at 5 years for patients with LRR after BCT is between 76% and 92% [13], [20], [55], [56]. The median time to second relapse after LRR is 97 months, and the median survival time is 103 months [55].
The prognosis at LRR is dependent on several factors, including the
Status of axillary lymph nodes
The status of the axillary lymph nodes at the initial BCT as well as at the time of the LRR are important prognostic factors [17], [35], [56], [60]. Patients with negative nodes at the primary BCT have an 8% incidence of distant metastases at the LRR, compared with 36% for those with 1 to 3 positive nodes, and 50% for those with 4 of more positive nodes [60]. The status of the axillary lymph nodes at the time of salvage surgery also has an impact on outcome. Patients with negative axillary
Conclusions
The majority of small invasive and noninvasive breast cancers are treated today by BCT, which includes wide local excision with negative surgical margins and radiation treatment to the breast. Studies have shown the incidence of LRR after BCT for stage 0, I, and II patients to range from 5% to 22%. The factors increasing the risk for LRR are positive margins, the presence of high-grade DCIS, young patient age, and the absence of radiation therapy at the time of the initial BCT.
Patients who are
References (61)
- et al.
Salvage treatment for local recurrence following breast conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast
Int J Radiat Oncol Biol Phys
(1994) - et al.
Conservative surgery and radiation therapy in breast carcinomaLocal recurrence and prognostic implications
Int J Radiat Oncol Biol Phys
(1989) - et al.
Breast relapse following primary radiation therapy for early breast cancer
Int J Radiat Oncol Biol Phys
(1985) - et al.
Long-term results of local recurrence after breast conservation treatment for invasive breast cancer
Int J Radiat Oncol Biol Phys
(2001) - et al.
The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive irradiation for early stage breast cancer
Int J Radiat Oncol Biol Phys
(1991) Surgical considerations for invasive breast cancer
Surg Clin North Am
(1999)- et al.
Management of DCIS
Surg Clin North Am
(1999) - et al.
Microinvasive ductal carcinoma of the breast treated with breast-conserving surgery and definitive irradiation
Int J Radiat Oncol Biol Phys
(1992) Factors influencing the risk of local recurrence in the breast
Eur J Cancer
(1992)- et al.
Women 35 years of age or younger have higher locoregional relapse rates after undergoing breast conservation therapy
J Am Coll Surg
(1998)
Radiotherapy in breast conserving treatment for ductal carcinoma in situFirst results of the EORTC randomised phase III trial 10853
Lancet
Duct carcinoma in situ227 cases without microinvasion
Eur J Cancer
Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma
Int J Radiat Oncol Biol Phys
Reoperative sentinel lymph node biopsyA new option for patients with primary or locally recurrent breast carcinoma
J Am Coll Surg
Presentation, management and outcome of axillary recurrence from breast cancer
Am J Surg
The prognostic significance of late local recurrence after breast-conserving therapy
Int J Radiat Oncol Biol Phys
Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer
N Engl J Med
The national cancer institute audit of the national surgical adjuvant breast and bowel project protocol B-06
N Engl J Med
Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
N Engl J Med
Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer
N Engl J Med
Fifteen year prognostic discriminants for invasive breast carcinoma
Cancer
Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06
Cancer
Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast
N Engl J Med
Lumpectomy and radiation therapy for the treatment of intraductal breast cancerFindings from national surgical adjuvant breast and bowel project B-17
JCO
Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer
N Engl J Med
Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17
Cancer
Local recurrence after breast-conserving surgery and radiotherapy
Cancer
Salvage surgery for recurrences after breast conservation
World J Surg
Management of locally recurrent breast cancer
Cancer
Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy
Cancer
Cited by (109)
3D printing‐based drug-loaded implanted prosthesis to prevent breast cancer recurrence post‐conserving surgery
2021, Asian Journal of Pharmaceutical SciencesUsefulness of intraoperative surgical margin assessment for the diagnosis of margin involvement in breast-conserving surgery
2021, Revista de Senologia y Patologia MamariaBreast reconstruction after breast conservation therapy for breast cancer
2018, European Journal of Obstetrics and Gynecology and Reproductive BiologyCitation Excerpt :Maximizing patients’ survival and minimizing treatment’s morbidity are the keystones in breast cancer treatment and breast cancer research [1]. Conservative surgery followed by breast irradiation, often referred to as Breast conserving therapy (BCT), has replaced modified radical mastectomy for the treatment of early stage invasive breast cancer [2–4]. Multiple trials proved equivalent disease-free and overall survival outcomes when patients with early stages of breast cancer are treated with partial mastectomy (lumpectomy/quadrantectomy) and radiation therapy or modified radical mastectomy [2–4].
Can Locoregionally Recurrent Breast Cancer Be Cured?
2017, Clinical Breast CancerReirradiation for locally recurrent breast cancer
2017, BreastCitation Excerpt :Excision of the tumor alone results in high recurrence rates of up to 35% [8,9], rates similar to those of excision alone for upfront treatment of newly diagnosed breast cancers. Therefore, salvage mastectomy is considered the standard of care in cases of local relapse after prior BCT [10,11]. The local control rate following salvage mastectomy ranges from 48% to 95% [12–15].
<sup>125</sup>I radioactive seed localization for non-palpable lesions in breast cancer
2019, Revista Espanola de Medicina Nuclear e Imagen Molecular